European Commission allows Glycom A/S to place lacto-N-tetraose (‘LNT’), obtained by microbial fermentation with a genetically modified strain of Escherichia coli, strain K12 DH1, on the Union market as a novel food. CLICK HERE Tags: HMO, LNT, novel food Read more articles Previous PostFermented Food Consumption Associated with Changes in the Gut Microbiome Next PostThe Global Prebiotic Association Welcomes FrieslandCampina Ingredients as a New Member You Might Also Like A Comprehensive Literature Review from 2012 to 2023 Examining Their Impact on Human Health Across Seven Major Conditions February 14, 2024 Fermentation of Pleurotus ostreatus and Ganoderma lucidum mushrooms and their extracts by the gut microbiota of healthy and osteopenic women: potential prebiotic effect and impact of mushroom fermentation products on human osteoblasts February 1, 2021 Prebiotic claim awarded for inulin and oligofructose in Indonesia May 19, 2021
A Comprehensive Literature Review from 2012 to 2023 Examining Their Impact on Human Health Across Seven Major Conditions February 14, 2024
Fermentation of Pleurotus ostreatus and Ganoderma lucidum mushrooms and their extracts by the gut microbiota of healthy and osteopenic women: potential prebiotic effect and impact of mushroom fermentation products on human osteoblasts February 1, 2021